Literature DB >> 2981520

Reoperation for persistent and recurrent hyperparathyroidism.

M F Brennan, J A Norton.   

Abstract

As a consequence of an experience with 175 patients undergoing reoperation for persistent or recurrent hyperparathyroidism, the authors have evolved an approach to management. The emphasis is on the confirmation of the diagnosis; the critical evaluation of invasive and noninvasive localization tests, techniques of intraoperative assessment as to the adequacy of the reexploration; the avoidance of postoperative complications; the treatment with cryopreserved autografts of persistent hypocalcemia. With this approach, the authors have had a success rate of greater than 90% for reexploration in patients with persistent and recurrent hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981520      PMCID: PMC1250616     

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  Preoperative localization of abnormal parathyroid: neck massage versus arteriography and selective venous sampling.

Authors:  A M Spiegel; J L Doppman; S J Marx; M F Brennan; E M Brown; R W Downs; D G Gardner; M Attie; G D Aurbach
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

2.  Serum calcium survey for hyperparathyroidism: results in 50,000 clinic patients.

Authors:  C E Boonstra; C E Jackson
Journal:  Am J Clin Pathol       Date:  1971-05       Impact factor: 2.493

3.  Recurrent hyperparathyroidism from an autotransplanted parathyroid adenoma.

Authors:  M F Brennan; E M Brown; S J Marx; A M Spiegel; A E Broadus; J L Doppman; B Webber; G D Aurbach
Journal:  N Engl J Med       Date:  1978-11-09       Impact factor: 91.245

4.  Persistent postoperative hyperparathyroidism.

Authors:  J K Martin; J A van Heerden; A J Edis; D C Dahlin
Journal:  Surg Gynecol Obstet       Date:  1980-12

5.  Reoperative parathyroid surgery for primary hyperparathyroidism caused by multiple-gland disease: total parathyroidectomy and autotransplantation with cryopreserved tissue.

Authors:  A W Saxe; M F Brennan
Journal:  Surgery       Date:  1982-06       Impact factor: 3.982

6.  Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration.

Authors:  S J Marx; J L Stock; M F Attie; R W Downs; D G Gardner; E M Brown; A M Spiegel; J L Doppman; M F Brennan
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

7.  Assessment of techniques for preoperative parathyroid gland localization in patients undergoing reoperation for hyperparathyroidism.

Authors:  M F Brennan; J L Doppman; A G Kurdy; S J Marx; A M Spiegel; G D Aurbach
Journal:  Surgery       Date:  1982-01       Impact factor: 3.982

8.  Primary hyperparathyroidism: changes in the pattern of clinical presentation.

Authors:  G R Mundy; D H Cove; R Fisken
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

9.  Results of reoperation for persistent and recurrent hyperparathyroidism.

Authors:  M F Brennan; S J Marx; J Doppman; J Costa; A Saxe; A Spiegel; A Krudy; G Aurbach
Journal:  Ann Surg       Date:  1981-12       Impact factor: 12.969

10.  Parathyroid imaging after intraarterial injections of [75Se]selenomethionine.

Authors:  J L Stock; A G Krudy; J L Doppman; A E Jones; M F Brennan; M F Attie; R W Downs; M A Levine; S J Marx; A M Spiegel; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

View more
  24 in total

1.  Causes of failed primary exploration and technical aspects of re-operation in primary hyperparathyroidism.

Authors:  G Akerström; C Rudberg; L Grimelius; H Johansson; B Lundström; J Rastad
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

2.  Undescended parathyroid adenomas as cause of persistent hyperparathyroidism.

Authors:  Paula Rioja; Germán Mateu; Leyre Lorente-Poch; Juan J Sancho; Antonio Sitges-Serra
Journal:  Gland Surg       Date:  2015-08

Review 3.  [Reoperation for primary hyperparathyroidism].

Authors:  E Karakas; A Zielke; C Dietz; M Rothmund
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

4.  Management of patients with persistent or recurrent primary hyperparathyroidism.

Authors:  S E Carty; J A Norton
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 5.  Reoperative surgery for persistent hyperparathyroidism.

Authors:  R M Beazley
Journal:  J Natl Med Assoc       Date:  1988-05       Impact factor: 1.798

6.  Prospective comparison of radionuclide, ultrasound, and computed tomography in the preoperative localization of parathyroid glands.

Authors:  H L Carmalt; D J Gillett; J Chu; R A Evans; S Kos
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

7.  Persistent primary hyperparathyroidism caused by adenomas identified in pharyngeal or adjacent structures.

Authors:  Teresa J Chan; Steven K Libutti; J Andrea McCart; Clara Chen; Anjum Khan; Monica K Skarulis; Lee S Weinstein; John L Doppman; Stephen J Marx; H Richard Alexander
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

8.  Reoperation for parathyroid adenoma: a contemporary experience.

Authors:  Anathea C Powell; H Richard Alexander; Richard Chang; Stephen J Marx; Monica Skarulis; James F Pingpank; David L Bartlett; Marybeth Hughes; Lee S Weinstein; William F Simonds; Michael F Collins; Thomas Shawker; Clara C Chen; James Reynolds; Craig Cochran; Seth M Steinberg; Steven K Libutti
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

9.  Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism.

Authors:  G M Doherty; J L Doppman; D L Miller; M S Gee; S J Marx; A M Spiegel; G D Aurbach; H I Pass; M F Brennan; J A Norton
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

10.  Closed mediastinal exploration in patients with persistent hyperparathyroidism.

Authors:  S A Wells; J D Cooper
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.